Villere St Denis J & CO LLC Abbott Laboratories Transaction History

Villere St Denis J & CO LLC

$1.15 Billion
Q3 2024

A detailed history of Villere St Denis J & CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Villere St Denis J & CO LLC holds 251,709 shares of ABT stock, worth $29.4 Million. This represents 2.49% of its overall portfolio holdings.

Number of Shares

251,709

Previous 256,324 1.8%

Holding current value

$29.4 Million

Previous $26.6 Million 7.75%

% of portfolio

2.49%

Previous 2.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $461,823 - $545,169	-4,615 Reduced 1.8%	251,709 $28.7 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $1,410 - $1,574	14 Added 0.01%	256,324 $26.6 Million
Q1 2024 Apr 25, 2024	BUY	$109.52 - $120.96 $8.3 Million - $9.17 Million	75,820 Added 42.01%	256,310 $29.1 Million
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $1.68 Million - $2.06 Million	-18,620 Reduced 9.35%	180,490 $19.9 Million
Q3 2023 Oct 20, 2023	SELL	$95.53 - $114.62 $359,383 - $431,200	-3,762 Reduced 1.85%	199,110 $19.3 Million
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $272,307 - $303,407	-2,702 Reduced 1.31%	202,872 $22.1 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $44,652 - $52,558	-461 Reduced 0.22%	205,574 $20.8 Million
Q4 2022 Jan 18, 2023	SELL	$95.06 - $111.52 $348,299 - $408,609	-3,664 Reduced 1.75%	206,035 $22.6 Million
Q3 2022 Oct 17, 2022	SELL	$96.76 - $112.03 $9,676 - $11,203	-100 Reduced 0.05%	209,699 $20.3 Million
Q2 2022 Jul 18, 2022	BUY	$102.07 - $123.37 $232,923 - $281,530	2,282 Added 1.1%	209,799 $22.8 Million
Q1 2022 Apr 19, 2022	BUY	$114.02 - $139.04 $2.03 Million - $2.47 Million	17,775 Added 9.37%	207,517 $24.6 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $944,226 - $1.16 Million	-8,173 Reduced 4.13%	189,742 $26.7 Million
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $291,066 - $322,004	-2,495 Reduced 1.24%	197,915 $23.4 Million
Q2 2021 Jul 19, 2021	SELL	$105.79 - $124.53 $77,226 - $90,906	-730 Reduced 0.36%	200,410 $23.2 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $315,636 - $371,866	-2,900 Reduced 1.42%	201,140 $24.1 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $182,700 - $199,090	-1,740 Reduced 0.85%	204,040 $22.3 Million
Q3 2020 Oct 27, 2020	BUY	$91.64 - $111.29 $203,899 - $247,620	2,225 Added 1.09%	205,780 $22.4 Million
Q2 2020 Jul 29, 2020	SELL	$76.57 - $98.0 $313,937 - $401,800	-4,100 Reduced 1.97%	203,555 $18.6 Million
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $25,128 - $36,744	-400 Reduced 0.19%	207,655 $16.4 Million
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $29,048 - $32,338	-370 Reduced 0.18%	208,055 $18.1 Million
Q3 2019 Oct 22, 2019	SELL	$81.84 - $88.74 $4,092 - $4,437	-50 Reduced 0.02%	208,425 $17.4 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $236,859 - $276,250	-3,250 Reduced 1.54%	208,475 $17.5 Million
Q1 2019 May 01, 2019	BUY	$66.22 - $80.06 $392,022 - $473,955	5,920 Added 2.88%	211,725 $16.9 Million
Q4 2018 Jan 22, 2019	SELL	$65.56 - $74.27 $125,219 - $141,855	-1,910 Reduced 0.92%	205,805 $14.9 Million
Q3 2018 Oct 30, 2018	SELL	$60.81 - $73.36 $1.38 Million - $1.67 Million	-22,700 Reduced 9.85%	207,715 $15.2 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $250,429 - $276,399	-4,350 Reduced 1.85%	230,415 $14.1 Million
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $939,709 - $1.06 Million	-16,700 Reduced 6.64%	234,765 $14.1 Million
Q4 2017 Jan 25, 2018	SELL	$53.68 - $57.47 $566,055 - $606,021	-10,545 Reduced 4.02%	251,465 $14.4 Million
Q3 2017 Oct 31, 2017	BUY	$48.06 - $53.64 $12.6 Million - $14.1 Million	262,010	262,010 $14 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Villere St Denis J & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Villere St Denis J & CO LLC with notifications on news.

Account

Villere St Denis J & CO LLC Abbott Laboratories Transaction History